Lead Migration During the Spinal Cord Stimulation Trial Period and Therapeutic Response

Sponsor
Augusta University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05956548
Collaborator
(none)
36
1
12
3

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare lead migration distance and therapeutic response for participants receiving a spinal cord stimulator during the trial period. Of note- scs trial period is a procedure name, not to be confused with this clinical trial study.

The main question[s] it aims to answer are:
  • Is there a difference in migration distance and/or rate for those with external leads secured by an anchor device versus and anchor device with suture?

  • How does participant activity levels during the trial period compare to migration rates? ° Does the temperature, heat index, and humidity during the trial period impact migration rates? Participants will come in for the scs trial procedure as normal. They will be asked to complete an activity survey upon return to the clinic for lead pull after the scs trial. They will also have an additional image upon return to the clinic to document lead position prior to lead pull.

Researchers will compare two groups- those with securement via anchor and those with securement via anchor and suture to see if there is an impact on therapeutic effect (percentage of pain relief) form the scs trial.

Condition or Disease Intervention/Treatment Phase
  • Procedure: external securement of scs leads during the scs trial period
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Contrasting Lead Migration During Spinal Stimulation Trial Period Against Therapeutic Response - Evaluating Securement Methods During the Trial Period
Anticipated Study Start Date :
Jul 15, 2023
Anticipated Primary Completion Date :
May 14, 2024
Anticipated Study Completion Date :
Jul 14, 2024

Outcome Measures

Primary Outcome Measures

  1. Therapeutic Response [SCS trial periods are 3-6 days at our facilty.]

    % of pain relief achieved by the participant during the SCS trial period

  2. Lead position changes (migration) [the last day of the trial period which could be day 3 up to day 6, depending on length]

    final location of the SCS leads at the end of the scs trial period, as seen on imaging

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Adults ages 18 and over without a failed spinal stimulation trial or implant will be accepted into the study. Patients must have a diagnosis of chronic back pain and must be patients of the identified anesthesiologists and have their procedures performed at AUHS pain clinic.

Exclusion Criteria:

Patients will be excluded if they have a history of local anesthetic allergy (lidocaine), current skin infections at the procedure site, or a diagnosis of diaphoresis/ secondary hyperhidrosis (chronic over sweating).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Augusta University Health System Pain Clinic Augusta Georgia United States 30912

Sponsors and Collaborators

  • Augusta University

Investigators

  • Study Chair: Jeane Silva, PhD, Augusta University
  • Principal Investigator: Stephanie C Jones, Grad Student, Augusta University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephanie Jones, Principal Investigator, Augusta University
ClinicalTrials.gov Identifier:
NCT05956548
Other Study ID Numbers:
  • 1994689
First Posted:
Jul 21, 2023
Last Update Posted:
Jul 21, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 21, 2023